Corient Private Wealth
RMD icon

Corient Private Wealth’s ResMed RMD Stock Holding History

Corient Private Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Sell
83,995
-8,507
-9% -$1.76M 0.02% 484
2026
Q1 		$20.7M Buy
92,502
+4,704
+5% +$1.17M 0.03% 393
2025
Q4 		$21.1M Buy
87,798
+2,560
+3% +$655K 0.03% 395
2025
Q3 		$23.3M Sell
85,238
-1,523
-2% -$416K 0.04% 362
2025
Q2 		$22.4M Buy
86,761
+1,329
+2% +$317K 0.03% 372
2025
Q1 		$19.1M Buy
85,432
+2,448
+3% +$571K 0.03% 396
2024
Q4 		$19M Sell
82,984
-2,974
-3% -$716K 0.03% 399
2024
Q3 		$21M Buy
85,958
+5,298
+7% +$1.18M 0.03% 410
2024
Q2 		$15.4M Sell
80,660
-826
-1% -$168K 0.03% 436
2024
Q1 		$16.1M Buy
81,486
+15,552
+24% +$2.85M 0.03% 428
2023
Q4 		$11.3M Buy
65,934
+1,413
+2% +$217K 0.02% 488
2023
Q3 		$9.55M Buy
64,521
+10,892
+20% +$1.97M 0.02% 490
2023
Q2 		$11.7M Sell
53,629
-53
-0.1% -$11.8K 0.03% 450
2023
Q1 		$11.8M Buy
53,682
+39,559
+280% +$8.58M 0.03% 411
2022
Q4 		$2.94M Buy
+14,123
New +$3.1M 0.01% 612

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Corient Private Wealth's RMD Position: Q2 2026 in Review

Corient Private Wealth reduced its ResMed (RMD) stake by 9.2% in Q2 2026, selling an estimated $1.76M and leaving 83,995 shares worth $16.4M. The position accounts for 0.02% of the portfolio, ranked #484.

Corient Private Wealth first reported a position in RMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $23.3M in Q3 2025. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Corient Private Wealth held 83,995 shares of ResMed worth $16.4M as of Q2 2026.
  • Corient Private Wealth sold 8,507 ResMed shares in Q2 2026, an estimated $1.76M.
  • ResMed made up 0.02% of Corient Private Wealth's portfolio in Q2 2026, its #484 holding.
  • Corient Private Wealth first reported a position in ResMed in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's ResMed position peaked at $23.3M in Q3 2025.
  • 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.